Documenting barriers to access for a cell/gene therapy

Goal

The initiative led by government affairs was triggered by unexpectedly low penetration rates of the therapy in multiple EU countries. The initiative aimed to assemble evidence on systemic access barriers leading to patient drop-off along the patient journey, to identify root causes of the barriers, and to initiate collaborations amongst healthcare stakeholders to co-develop solutions.

Approach

Analyze drop-off along patient journey & uncover barriers

We examined existing public and internal data to understand where patients are lost along the patient journey. We hypothesized different barriers that may exist at the points at which high numbers of patients were dropping out.

Identify systemic issues & root causes

We identified and validated the systemic issues with external stakeholders and identified several root causes along the patient journey across multiple countries.

Co-develop solutions & explore collaboration opportunities

After validating the root causes for the systemic issues, solutions ideas were discussed by the multi-stakeholder panel.

The initiative and collaborative approach was very well received by external stakeholders
Discussions with the multistakeholder panel initiated several follow-on activities and collaborations aiming to resolve the documented barriers
The methodology has been integrated in the client way of working and will be further rolled out

Contact our experts

Andrea Sobrio

Founder and Managing Partner

Philippe Coune

Director

Anna Lenard

Manager

Learn more about our focus topic

Environment Transformation

We use cookies to ensure we give you the best experience on our website. Detailed information on the use of cookies, and how you can disable them, is provided in our Privacy Policy. By using this site or clicking on "OK", you consent to the use of cookies.